SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ATIS is on the move!
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
2205 22 0 ATIS
Emcee:  Rick Costantino Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
605 Narayan, Haven't said that good news will come by summer, but that it is lMarshall Teitelbaum-2/26/1997
604 Thank you Marshall for your detailed explanation. I do believe that ATIS has gNarayan Murarka-2/26/1997
603 Actually cloning is what ATIS does in a sense. Taking cells and duplicating theGreg Boris-2/26/1997
602 Hi, Henry, and welcome to ATIS thread. I'd like to introduce you to those WWS-2/26/1997
601 For a discussion of adult cloning and PPL Therapeutics go to PPL Therapeutics -Henry Niman-2/26/1997
600 Marshall; I don't own shares in GENZL or ATIS. I stumbled upon ATIS as parVector1-2/26/1997
599 Greg, FWIW, I was told by ATIS that financials are due out shortly...forgot wMarshall Teitelbaum-2/25/1997
598 Paul, Although I appreciate your interest and knowledge, I think you are startMarshall Teitelbaum-2/25/1997
597 Narayan, Not necessarily. First of all, the key to forward movement in the inMarshall Teitelbaum-2/25/1997
596 Greg: I talked to Investers Relations at ATIS today to find out the latest staNarayan Murarka-2/25/1997
595 Hi Greg & Marshall: As I mentioned before, I've read what you've pPaul A Kloepper-2/25/1997
594 Marshall, thanks for the additional info. FDA movement is trying our patience, Greg Boris-2/25/1997
593 Greg, Thanks for posting these two articles, especially the first one. CoversMarshall Teitelbaum-2/24/1997
592 Other stuff Friday December 20 9:00 AM EDT Advanced Tissue Sciences Submits Greg Boris-2/24/1997
591 Information from ATIS' 10-K filed 2/96. ORTHOPEDIC PRODUCTS Many ofGreg Boris-2/24/1997
590 Yes the FDA usually follows the panel rec although the timing depends on whetheVector1-2/24/1997
589 Bruce, As of the last couple of months, I would generally agree. The ups are Marshall Teitelbaum-2/23/1997
588 Paul, I appreciate the nice thoughts. Opinions only are useful when they are Marshall Teitelbaum-2/23/1997
587 Marshall, Is it just me or does it seem that any movement in the price comes sBruce Long-2/22/1997
586 Thanks for hosting the ATIS string, Marshall. You do a good job of consideringPaul A Kloepper-2/22/1997
585 lwd, A lot of interesting questions and issues have been brought up. Thank yoMarshall Teitelbaum-2/21/1997
584 Greg: Thank you for the information and viewpoint. Do I get the Phase II descrlwd-2/21/1997
583 Vector 1: Thanks for the reply and info. Re:procedure backlog. I'm assuminglwd-2/21/1997
582 LWD Great posts. The most critical issue for GENZL is HMO acceptance and insuraVector1-2/21/1997
581 Based on their Phase II work which is published, success was 100% vs. control 0Greg Boris-2/21/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News